Table 2.
Variables | Patients with CRE BSI (N = 73) | Matched patients with CSE BSI (N = 73) | P valuea |
---|---|---|---|
n (%) | n (%) | ||
Type of BSI acquisitionb | |||
Nosocomial | 47 (64.4) | 47 (64.4) | 1.000 |
Community-onset healthcare-associated | 20 (27.4) | 20 (27.4) | |
Strict community-acquired | 6 (8.2) | 6 (8.2) | |
BSI sourcesb | |||
Urinary tract | 27 (37.0) | 27 (37.0) | 1.000 |
Pneumonia | 6 (8.2) | 6 (8.2) | |
Intra-abdominal | 11 (15.1) | 11 (15.1) | |
Intravascular catheter | 10 (13.7) | 10 (13.7) | |
Other | 3 (4.1) | 3 (4.1) | |
Unknown source | 16 (21.9) | 16 (21.9) | |
Pathogen | |||
Escherichia coli | 5 (6.8) | 30 (41.1) | <0.001 |
Klebsiella pneumoniae | 60 (82.2) | 25 (34.2) | |
Enterobacter cloacae | 3 (4.1) | 7 (9.6) | |
Other Enterobacteralesc | 5 (6.8) | 11 (15.1) | |
Carbapenemase producer among CRE | 70 (95.9) | ||
Type of carbapenemase | |||
OXA-48 | 35 (50.0) | ||
KPC (2/3) | 22 (31.4) | ||
NDM-1 | 6 (8.6) | ||
VIM (1/4) | 3 (4.3) | ||
Two types identifiedd | 4 (5.7) |
BSI, bloodstream infection; CRE, carbapenem-resistant Enterobacterales; CSE, carbapenem-susceptible Enterobacterales.
aBased on univariable conditional logistic regression.
bMatching variable.
cFor patients with CRE BSI, other Enterobacterales included Klebsiella species not K. pneumoniae (n = 1), Enterobacter species not E. cloacae (n = 1), Serratia species (n = 1), Proteus mirabilis (n = 1) and Citrobacter freundii (n = 1). For matched patients with CSE BSI, other Enterobacteriaceae included Klebsiella oxytoca (n = 1), Enterobacter aerogenes (n = 1), Serratia marcescens (n = 3), P. mirabilis (n = 3), Citrobacter species (n = 1), Morganella morganii (n = 1) and Providencia rettgeri (n = 1).
dOXA-48 and NDM-1 (n = 2), KPC-2 and VIM-1 (n = 1), and KPC-3 and NDM-1 (n = 1).